We've found
184,457
clinical trials
We've found
184,457
clinical trials
Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Atopy Clinical Trial
Updated: 9/28/2015
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK001
Status: Enrolling,
Phase
I
Updated: 9/28/2015
Click here to add this to my saved trials

Thromboembolism Clinical Trial
Updated: 12/21/2017
Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates
Status: Enrolling,
Phase
I, II
Updated: 12/21/2017
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Dietary Modification Clinical Trial
Updated: 1/18/2018
COntinuous vs BOlus Nasogastric Feeding in Mechanically Ventilated Pediatric Patients 2
Status: Enrolling
Updated: 1/18/2018
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Cisplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor M6620 in Treating Patients With Metastatic Urothelial Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Impact of CD34+ Cell Dose on Progression-free Survival Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Acne Vulgaris Clinical Trial
Updated: 2/29/2016
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials

Acne Vulgaris Clinical Trial
Updated: 2/29/2016
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials

Acne Vulgaris Clinical Trial
Updated: 2/29/2016
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials

Acne Vulgaris Clinical Trial
Updated: 2/29/2016
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials

Acne Vulgaris Clinical Trial
Updated: 2/29/2016
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials

Acne Vulgaris Clinical Trial
Updated: 2/29/2016
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials

Acne Vulgaris Clinical Trial
Updated: 2/29/2016
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials

Acne Vulgaris Clinical Trial
Updated: 2/29/2016
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Onalespib in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Diffuse Large B-Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Uterine Infertility Clinical Trial
Updated: 12/31/1969
Uterine Transplantation for the Treatment of Uterine Factor Infertility
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Solid Tumors Habouring NTRK Fusion Clinical Trial
Updated: 12/31/1969
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Chemotherapy-Induced Nausea and Vomiting Clinical Trial
Updated: 7/28/2016
Efficacy and Safety Study of Fosaprepitant (MK-0517) Plus Ondandsetron Versus Ondansetron Alone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-044)
Status: Enrolling,
Phase
III
Updated: 7/28/2016
Click here to add this to my saved trials

Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cleft Palate Clinical Trial
Updated: 10/20/2015
Improving Outcomes in Cleft Palate Surgery
Status: Enrolling
Updated: 10/20/2015
Click here to add this to my saved trials

Atrial Fibrillation Clinical Trial
Updated: 12/31/1969
Feasibility Study of a Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

HIV Prevention Clinical Trial
Updated: 2/7/2018
Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women
Status: Enrolling,
Phase
IV
Updated: 2/7/2018
Click here to add this to my saved trials

Non Arteritic Anterior Ischemic Optic Neuropathy Clinical Trial
Updated: 12/31/1969
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Non Arteritic Anterior Ischemic Optic Neuropathy Clinical Trial
Updated: 12/31/1969
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Non Arteritic Anterior Ischemic Optic Neuropathy Clinical Trial
Updated: 12/31/1969
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Non Arteritic Anterior Ischemic Optic Neuropathy Clinical Trial
Updated: 12/31/1969
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Embolism Clinical Trial
Updated: 12/31/1969
Predicting the Safety and Effectiveness of Inferior Vena Cava Filters
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Embolism Clinical Trial
Updated: 12/31/1969
Predicting the Safety and Effectiveness of Inferior Vena Cava Filters
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Neurology Clinical Trial
Updated: 12/31/1969
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Neurology Clinical Trial
Updated: 12/31/1969
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Neurology Clinical Trial
Updated: 12/31/1969
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Advanced Solid Tumours Clinical Trial
Updated: 12/31/1969
Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer.
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials

Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials

Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials

Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials

Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials

Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials

Juvenile Idiopathic Arthritis Clinical Trial
Updated: 12/31/1969
Efficacy Study Of Tofacitinib In Pediatric JIA Population
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Juvenile Idiopathic Arthritis Clinical Trial
Updated: 12/31/1969
Efficacy Study Of Tofacitinib In Pediatric JIA Population
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Juvenile Idiopathic Arthritis Clinical Trial
Updated: 12/31/1969
Efficacy Study Of Tofacitinib In Pediatric JIA Population
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Juvenile Idiopathic Arthritis Clinical Trial
Updated: 12/31/1969
Efficacy Study Of Tofacitinib In Pediatric JIA Population
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
